Harvinder Virk, MA (Oxon), PhD, MRCP

Dr. Harvinder Virk is a clinician and scientist at the University of Leicester, UK and the academic lead of the YCharOS UK lab. He is a member of the Royal College of Physicians and sits on the Supervisory Board of the UK Reproducibility Network. He is a previous MRC Clinical Research Training Fellowship holder and current MRC New Investigator (Better Methods, Better Research).

His research centers around identifying and overcoming barriers to the translation of research for patient benefit. He co-leads the Only Good Antibodies team and their three linked interdisciplinary projects: Better Antibodies, Better Science, and Better Patient Outcomes. These projects look to identify the most suitable research tools (antibodies), promote their appropriate use, and empower them towards better characterization of patient heterogeneity. The vision is robust tools for basic science, and validated diagnostics that help clinicians choose the best treatment, or clinical trial, more efficiently and robustly.